NILM Pap Slides From Women 30 Years of Age and Older With Positive High-Risk HPV DNA
Author(s) -
Karen Cormier,
Michael Schaaf,
Stephanie Hamilton,
Ronald Tickman,
Nuria PerezReyes,
Charles D. Sturgis
Publication year - 2014
Publication title -
american journal of clinical pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.859
H-Index - 128
eISSN - 1943-7722
pISSN - 0002-9173
DOI - 10.1309/ajcp98enfcnokvae
Subject(s) - papanicolaou stain , squamous intraepithelial lesion , medicine , papanicolaou test , concomitant , population , gynecology , dna testing , human papillomavirus , obstetrics , malignancy , cervical intraepithelial neoplasia , cancer , cervical cancer , biology , genetics , environmental health
Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) regulations specify that at least 10% of negative Papanicolaou (Pap) slides be rescreened as a quality control (QC) measure. With incorporation of human papillomavirus (HPV) DNA testing into screening guidelines for women aged 30 years or older, a population of patients exists who are HPV positive as well as negative for intraepithelial lesion or malignancy (NILM).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom